subject: UMLS:C0055108


subject: UMLS:C0055108

subject_name: cerebrolysin

object_name: CADASIL 1

tested_intervention: unsure


subject: UMLS:C4547475

object_name: cystic fibrosis

tested_intervention: yes


subject: CHEBI:50858

subject_name: corticosteroid

object_name: Myasthenia Gravis, Ocular


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UMLS:C4755183

subject_name: Vigabatrin only product

object_name: Status Epilepticus, Subclinical


subject: UMLS:C4755183

object_name: ocular motor apraxia, Cogan type


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: unspecified childhood solid tumor, protocol specific


subject: CHEBI:59905

object_name: Blood Pressure Finding


subject: CHEBI:59905

object_name: Systemic arterial pressure


subject: CHEBI:59905

object_name: fetal growth restriction


subject: CHEBI:18243

subject_name: Dopamine


subject: CHEBI:18243


subject: CHEBI:18243


subject: CHEBI:17650

subject_name: Hydrocortisone


subject: CHEBI:17650


subject: CHEBI:17650

object_name: hypotension


subject: CHEBI:17650

object_name: Hypotension, CTCAE


subject: UMLS:C2347460

subject_name: Maxy G34

object_name: Childhood Breast Carcinoma


subject: UMLS:C2347460

object_name: breast carcinoma


subject: UMLS:C2347460

object_name: breast cancer


subject: UMLS:C2347460

object_name: Chemotherapy induced neutropenia


subject: UMLS:C5958948

subject_name: Lutetium Lu 177 FF58

object_name: glioblastoma


subject: UMLS:C5958948

object_name: Brain Stem Glioblastoma


subject: UMLS:C5958948

object_name: glioma susceptibility 1


subject: UMLS:C5958948

object_name: pancreatic ductal adenocarcinoma


subject: UMLS:C5958948

object_name: gastroesophageal adenocarcinoma


subject: UNII:W1NYL2IRDR

subject_name: PALBOCICLIB ISETHIONATE

object_name: Recurrent Childhood Gliosarcoma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Glioblastoma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Pineoblastoma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Medulloblastoma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Brain Stem Glioma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Giant Cell Glioblastoma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Gliomatosis Cerebri


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Anaplastic Astrocytoma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Anaplastic Oligoastrocytoma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Anaplastic Oligodendroglioma


subject: UNII:W1NYL2IRDR

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UNII:W1NYL2IRDR

object_name: childhood choroid plexus neoplasm


subject: UNII:W1NYL2IRDR

object_name: Childhood Glioblastoma


subject: UNII:W1NYL2IRDR

object_name: childhood high-grade cerebellar astrocytoma


subject: UNII:W1NYL2IRDR

object_name: Childhood Grade III Meningioma


subject: UNII:W1NYL2IRDR

object_name: childhood medulloepithelioma


subject: UNII:W1NYL2IRDR

object_name: pediatric cerebral ependymoblastoma


subject: UMLS:C3896941

subject_name: Palbociclib Isethionate

object_name: Recurrent Childhood Gliosarcoma


subject: UMLS:C3896941

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C3896941

object_name: Recurrent Childhood Pineoblastoma


subject: UMLS:C3896941

object_name: Recurrent Childhood Medulloblastoma


subject: UMLS:C3896941

object_name: Recurrent Childhood Brain Stem Glioma


subject: UMLS:C3896941

object_name: Recurrent Childhood Giant Cell Glioblastoma


subject: UMLS:C3896941

object_name: Recurrent Childhood Gliomatosis Cerebri


subject: UMLS:C3896941

object_name: Recurrent Childhood Cerebral Astrocytoma


subject: UMLS:C3896941

object_name: Recurrent Childhood Cerebellar Astrocytoma


subject: UMLS:C3896941

object_name: Recurrent Childhood Anaplastic Astrocytoma


subject: UMLS:C3896941

object_name: Recurrent Childhood Anaplastic Oligoastrocytoma


subject: UMLS:C3896941

object_name: Recurrent Childhood Anaplastic Oligodendroglioma


subject: UMLS:C3896941

object_name: Recurrent Childhood Supratentorial Embryonal Tumor, Not Otherwise Specified


subject: UMLS:C3896941

object_name: childhood choroid plexus neoplasm


subject: UMLS:C3896941

object_name: Childhood Glioblastoma


subject: UMLS:C3896941

object_name: childhood high-grade cerebellar astrocytoma


subject: UMLS:C3896941

object_name: Childhood Grade III Meningioma


subject: UMLS:C3896941

object_name: childhood medulloepithelioma


subject: UMLS:C3896941

object_name: pediatric cerebral ependymoblastoma


subject: GTOPDB:8928

subject_name: pamrevlumab

object_name: COVID-19 respiratory infection


subject: GTOPDB:8928

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEMBL.COMPOUND:CHEMBL2109377

subject_name: PAMREVLUMAB


subject: CHEMBL.COMPOUND:CHEMBL2109377


subject: UMLS:C2985186


subject: UMLS:C2985186


subject: CHEBI:65353

subject_name: Lorcaserin

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:65353

object_name: digestive system carcinoma


subject: CHEBI:65350

subject_name: lorcaserin hydrochloride

object_name: Peripheral neuropathy due to and following antineoplastic therapy


subject: CHEBI:65350

object_name: Anatomic Stage I Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage I Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage II Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage II Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage III Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage III Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage IIB Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage IIA Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage IB Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage IA Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Anatomic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage IB Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage IA Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage IIIC Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: Prognostic Stage IIIA Breast Cancer AJCC v8


subject: CHEBI:65350

object_name: digestive system carcinoma


subject: CHEBI:52763

object_name: peripheral vertigo


subject: UMLS:C3502775

object_name: cervical cancer


subject: UMLS:C3502775

object_name: cervical carcinoma


subject: UMLS:C3502775

object_name: endometrial cancer


subject: UMLS:C3502775

object_name: uterine corpus cancer


subject: UMLS:C3502775

object_name: endometrial carcinoma


subject: UMLS:C3502775

object_name: ovarian cancer


subject: UMLS:C3502775

object_name: ovarian neoplasm


subject: UMLS:C3502775

object_name: ovarian carcinoma


subject: UMLS:C3502775

object_name: HER2 positive


subject: UMLS:C3502775

object_name: Estrogen Receptor Positive


subject: PUBCHEM.COMPOUND:42602260

subject_name: Capivasertib


subject: PUBCHEM.COMPOUND:42602260


subject: PUBCHEM.COMPOUND:42602260


subject: PUBCHEM.COMPOUND:42602260


subject: PUBCHEM.COMPOUND:42602260


subject: UNII:913P6LK81M

subject_name: Doravirine

object_name: pregnancy related


subject: UMLS:C3659413

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:72317

subject_name: Cabozantinib

object_name: melanoma


subject: PUBCHEM.COMPOUND:72760162

subject_name: Nalbuphine sebacate

object_name: Post-Operative Pain


subject: UNII:DFK0FC2VVV

subject_name: GEFAPIXANT CITRATE

object_name: Chronic cough


subject: UMLS:C5446747

subject_name: Gefapixant Citrate


subject: PUBCHEM.COMPOUND:135423438

subject_name: Nintedanib

object_name: Castleman disease


subject: CHEBI:85164


subject: UNII:K08BK043YS

subject_name: Vofopitant

object_name: bipolar disorder


subject: CHEBI:45716

subject_name: Vorinostat

object_name: von Hippel-Lindau disease


subject: UMLS:C5709300

subject_name: GliSODin

object_name: Melasma


subject: GTOPDB:12347

subject_name: penpulimab

object_name: colorectal cancer


subject: GTOPDB:12347

object_name: colorectal carcinoma


subject: GTOPDB:12347

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEMBL.COMPOUND:CHEMBL4297571

subject_name: PENPULIMAB


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: CHEMBL.COMPOUND:CHEMBL4297571


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: UMLS:C4723695


subject: GTOPDB:9674

subject_name: olaptesed pegol

object_name: metastatic colorectal cancer


subject: UNII:MTM792B442

subject_name: OLAPTESED PEGOL


subject: CHEBI:42941

object_name: esophageal squamous cell carcinoma


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Stage IVB Lung Cancer AJCC v8


subject: CHEBI:175901

object_name: Stage IVA Lung Cancer AJCC v8


subject: GTOPDB:13796

subject_name: serplulimab

object_name: Malignant neoplasm of colon stage IV


subject: CHEMBL.COMPOUND:CHEMBL4594550

subject_name: SERPLULIMAB


subject: UMLS:C4745029

subject_name: HLX 10


subject: CHEBI:63660

object_name: Crohn disease


subject: CHEBI:63618

subject_name: Pravastatin


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Senility


subject: UMLS:C4288872

object_name: Childhood Breast Carcinoma


subject: UMLS:C4288872

object_name: breast carcinoma


subject: UMLS:C4288872

object_name: breast cancer


subject: CHEMBL.COMPOUND:CHEMBL2108905

subject_name: BCG VACCINE

object_name: pertussis


subject: CHEMBL.COMPOUND:CHEMBL2108905

object_name: Whooping cough


subject: UMLS:C0004886

subject_name: BCG Vaccine


subject: UMLS:C0004886


subject: CHEBI:174615

object_name: brain cancer


subject: CHEBI:174615

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:174615

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:174615

object_name: soft tissue sarcoma


subject: CHEBI:174615

object_name: medulloblastoma


subject: CHEBI:174615

object_name: childhood medulloblastoma


subject: CHEBI:174615

object_name: adult medulloblastoma


subject: CHEBI:174615

object_name: hepatoblastoma


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: GTOPDB:4934

subject_name: G-CSF

object_name: kidney neoplasm


subject: GTOPDB:4934


subject: GTOPDB:4934

object_name: Childhood Soft Tissue Sarcoma


subject: GTOPDB:4934


subject: GTOPDB:4934

object_name: sarcoma


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934

object_name: Adult Rhabdomyosarcoma


subject: GTOPDB:4934

object_name: rhabdomyosarcoma


subject: GTOPDB:4934

object_name: Childhood Rhabdomyosarcoma


subject: GTOPDB:4934

object_name: Previously Treated Childhood Rhabdomyosarcoma


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: GTOPDB:4934


subject: CHEBI:5864

subject_name: Ifosfamide

object_name: central nervous system cancer


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:5864


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:31824

subject_name: Mesna


subject: CHEBI:17905

subject_name: Coenzyme M


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863

object_name: retinoblastoma


subject: CHEBI:9570

subject_name: Thiotepa

object_name: germ cell tumor


subject: CHEBI:9570


subject: CHEBI:9570

object_name: Adult Soft Tissue Sarcoma


subject: CHEBI:9570

object_name: Non-Metastatic Childhood Soft Tissue Sarcoma


subject: CHEBI:9570

object_name: soft tissue sarcoma


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9907

subject_name: ursodiol


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907

object_name: brain cancer


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907


subject: CHEBI:9907

object_name: medulloblastoma


subject: CHEBI:9907

object_name: childhood medulloblastoma


subject: CHEBI:9907

object_name: adult medulloblastoma


subject: CHEBI:9907

object_name: hepatoblastoma


subject: CHEBI:9907

object_name: liver carcinoma


subject: CHEBI:9907


subject: UNII:AHI9T7EDX6

subject_name: Pneumovax 23

object_name: acute lymphoblastic leukemia


subject: RXCUI:287523


subject: CHEBI:44915

subject_name: Propofol

object_name: Frailty


subject: UMLS:C5417852

object_name: Childhood Solid Neoplasm


subject: UMLS:C5417852

object_name: Adult Solid Neoplasm


subject: UMLS:C5417852

object_name: Solid Neoplasm


subject: UMLS:C5690683

object_name: inherited epidermolysis bullosa


subject: CHEBI:134252

object_name: Synkinesis


subject: CHEBI:134252

object_name: Facial Paresis


subject: CHEBI:134252

object_name: Bell's palsy


subject: CHEBI:2788

subject_name: Apraclonidine


subject: CHEBI:2788


subject: CHEBI:2788


subject: UMLS:C0360105

subject_name: Selective Serotonin Reuptake Inhibitors

object_name: Maternity blues


subject: CHEBI:35469

subject_name: antidepressant


subject: UMLS:C0003289

subject_name: Antidepressive Agents


subject: CHEBI:3770

subject_name: co-trimoxazole

object_name: diarrhea


subject: CHEBI:3770

object_name: rectal discharge diarrhea (physical finding)


subject: CHEBI:3770

object_name: Diarrhea, CTCAE


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C0041044


subject: UMLS:C2364569

subject_name: rotavirus vaccine, live attenuated, G1P[8] human 89-12 strain

object_name: Irritability


subject: UMLS:C2364569

object_name: Irritability, CTCAE


subject: UMLS:C2364569

object_name: Nausea, CTCAE_5


subject: UMLS:C2364569

object_name: Nausea


subject: UMLS:C2364569

object_name: Nausea, CTCAE_3


subject: UMLS:C2364569

object_name: Fever


subject: UMLS:C2364569

object_name: Fever symptoms (finding)


subject: UMLS:C2364569

object_name: Fever, CTCAE


subject: UMLS:C2364569

object_name: Vomiting


subject: MESH:D002136

subject_name: Calcium, Dietary

object_name: HIV infection


subject: UMLS:C3540037

subject_name: CALCIUM SUPPLEMENTS


subject: UNII:WY779SQ0XW

subject_name: CALCIUM


subject: CHEBI:29108

subject_name: Calcium cation


subject: CHEBI:22984

subject_name: Calcium


subject: UMLS:C2936886

subject_name: Calcium [EPC]


subject: UMLS:C3714611

subject_name: Calcium Drug Class


subject: CHEBI:32599

object_name: Acute Ischemic Stroke


subject: CHEBI:32599

object_name: Ischemic stroke


subject: UNII:366037O6O7

subject_name: Irosustat

object_name: breast neoplasm


subject: CHEBI:71013

subject_name: Perampanel

object_name: Torticollis


subject: CHEBI:131166

subject_name: Berzosertib

object_name: Recurrent Fallopian Tube Carcinoma


subject: CHEBI:131166

object_name: Recurrent Primary Peritoneal Carcinoma


subject: CHEBI:131166

object_name: Recurrent ovarian cancer


subject: CHEBI:131166

object_name: ovarian serous tumor


subject: CHEBI:28824

subject_name: stigmasterol

object_name: Hypercholesterolemia


subject: CHEBI:27693

subject_name: beta-Sitosterol


subject: CHEBI:85993

subject_name: Palbociclib

object_name: glioma susceptibility 1


subject: CHEBI:85993

object_name: adult oligodendroglioma


subject: CHEBI:85993

object_name: oligodendroglioma


subject: CHEBI:85993

object_name: childhood oligodendroglioma


subject: CHEBI:85993

object_name: Childhood Oligoastrocytoma


subject: CHEBI:85993

object_name: oligoastrocytoma


subject: UNII:X8BW0MQ5PI

object_name: plasma cell myeloma


subject: CHEBI:231598

subject_name: Tazemetostat


subject: UMLS:C1172402

subject_name: TS-1 titanium silicide


subject: UMLS:C2828372


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1135117

subject_name: Eloxatin


subject: CHEBI:73710

subject_name: Trp-Ala

object_name: Hypercholesterolemia, mild


subject: CHEBI:9635

subject_name: Toremifene

object_name: change; circulatory


subject: DRUGBANK:DB11360

subject_name: Lactobacillus plantarum

object_name: mood (physical finding)


subject: DRUGBANK:DB11360

object_name: Weight loss


subject: DRUGBANK:DB11360

object_name: Weight Loss, CTCAE


subject: DRUGBANK:DB17867

object_name: generalized dominant dystrophic epidermolysis bullosa


subject: DRUGBANK:DB17867

object_name: recessive dystrophic epidermolysis bullosa


subject: UNII:VDXVABRQTV

object_name: castration-resistant prostate carcinoma


subject: UNII:VDXVABRQTV

object_name: prostate carcinoma


subject: UNII:VDXVABRQTV

object_name: prostate cancer


subject: CHEBI:9130

subject_name: Sevoflurane

object_name: Thyroid nodule


subject: CHEBI:9130

object_name: nodule of thyroid by palpation


subject: CHEBI:16796

subject_name: Melatonin

object_name: liver disorder


subject: CHEBI:16796

object_name: Decreased liver function


subject: CHEBI:9168

subject_name: Sirolimus

object_name: B-cell neoplasm


subject: UNII:KZ3DLD11RQ

object_name: Advanced cancer


subject: UNII:KZ3DLD11RQ

object_name: non-small cell lung carcinoma


subject: UNII:KZ3DLD11RQ

object_name: colorectal cancer


subject: UNII:KZ3DLD11RQ

object_name: colorectal carcinoma


subject: UNII:KZ3DLD11RQ

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: UNII:KZ3DLD11RQ

object_name: adult hepatocellular carcinoma


subject: UNII:KZ3DLD11RQ

object_name: liver cancer


subject: UNII:KZ3DLD11RQ

object_name: pediatric hepatocellular carcinoma


subject: UNII:KZ3DLD11RQ

object_name: gastric adenocarcinoma


subject: UNII:KZ3DLD11RQ

object_name: melanoma


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: lung sarcomatoid carcinoma


subject: UNII:73096E137E


subject: UMLS:C4085979


subject: UNII:768FW21J3L

subject_name: Famitinib


subject: CHEBI:114785

subject_name: Erlotinib

object_name: esophageal disorder


subject: CHEBI:8869

subject_name: Risedronic acid

object_name: adult lymphoma


subject: CHEBI:8869

object_name: lymphoma


subject: CHEBI:8869

object_name: pediatric lymphoma


subject: CHEBI:8869

object_name: leukemia


subject: CHEBI:8869

object_name: childhood leukemia


subject: UMLS:C0016004

subject_name: Beriplast P

object_name: morbid obesity


subject: PUBCHEM.COMPOUND:53477767

subject_name: Hesperidin

object_name: Inflammatory Response


subject: PUBCHEM.COMPOUND:53477767

object_name: Muscle Atrophy


subject: PUBCHEM.COMPOUND:53477767

object_name: metabolic disturbance


subject: PUBCHEM.COMPOUND:53477767

object_name: Electrolyte imbalance


subject: PUBCHEM.COMPOUND:53477767

object_name: Abnormal blood ion concentration


subject: PUBCHEM.COMPOUND:53477767

object_name: Increased reactive oxygen species production


subject: PUBCHEM.COMPOUND:53477767

object_name: Abnormality of acid-base homeostasis


subject: PUBCHEM.COMPOUND:53477767

object_name: Hypoxemia


subject: PUBCHEM.COMPOUND:53477767

object_name: steatosis


subject: UMLS:C0085733

subject_name: Absolute Alcohol

object_name: osteoarthritis, knee


subject: UMLS:C0085733

object_name: chronic pain (diagnosis)


subject: UMLS:C0085733

object_name: Chronic pain


subject: CHEBI:16236

subject_name: Ethanol


subject: CHEBI:16236


subject: CHEBI:16236


subject: PUBCHEM.COMPOUND:135483998

object_name: cystic fibrosis


subject: PUBCHEM.COMPOUND:135402010


subject: CHEBI:20612


subject: CHEBI:15641

subject_name: 5-methyltetrahydrofolic acid


subject: CHEBI:28911

subject_name: cob(III)alamin


subject: PUBCHEM.COMPOUND:165339223

subject_name: Vitamin B 12


subject: HMDB:HMDB0000607

subject_name: Cyanocobalamin


subject: CHEBI:176843

subject_name: vitamin B12


subject: UMLS:C0086024

subject_name: cobalamins


subject: CHEBI:17439


subject: UMLS:C2936883

subject_name: Vitamin B12 [EPC]


subject: UNII:7DR7JMB8BH

object_name: ALK gene rearrangement positive


subject: UNII:SMA5ZS5B22

subject_name: Ensartinib


subject: UNII:G55ZH52P57

object_name: bacterial infectious disease


subject: UNII:G55ZH52P57

object_name: mycobacterial infectious disease


subject: UNII:G55ZH52P57

object_name: lung disorder


subject: CHEBI:31401

subject_name: Cilostazol

object_name: Cerebral microhaemorrhage


subject: CHEBI:31401

object_name: CADASIL


subject: CHEBI:31401

object_name: CADASIL 1


subject: CHEBI:23359

subject_name: colchicine

object_name: Primary gout


subject: CHEBI:23359

object_name: Gout flare


subject: CHEBI:5050

subject_name: Fexofenadine


subject: CHEBI:5050


subject: CHEBI:6931

subject_name: Midazolam


subject: CHEBI:6931


subject: UMLS:C3853885

object_name: Relapsing acute myeloid leukemia


subject: UMLS:C3853885

object_name: therapy related acute myeloid leukemia and myelodysplastic syndrome


subject: UMLS:C3853885

object_name: therapy-related myeloid neoplasm


subject: UMLS:C0593204

subject_name: Serdolect

object_name: schizophrenia


subject: UMLS:C0939309

subject_name: Depakote ER

object_name: Mania, CTCAE


subject: UMLS:C0939309

object_name: Mania


subject: UMLS:C0796383

object_name: Childhood Breast Carcinoma


subject: UMLS:C0796383

object_name: breast carcinoma


subject: UMLS:C0796383

object_name: breast cancer


subject: UMLS:C0796383

object_name: Embolism, Tumor


subject: UMLS:C0796383

object_name: Neoplasm Metastasis


subject: UMLS:C0796383

object_name: Metastasis


subject: UMLS:C0796383

object_name: Metastatic Lesion


subject: UNII:1S9VO1DQG5


subject: UNII:1S9VO1DQG5


subject: UNII:1S9VO1DQG5


subject: UNII:1S9VO1DQG5


subject: UNII:1S9VO1DQG5


subject: UNII:1S9VO1DQG5


subject: UNII:1S9VO1DQG5


subject: CHEBI:3219

subject_name: Bupropion

object_name: Tobacco withdrawal


subject: UNII:M89N0Q7EQR

subject_name: Aldesleukin

object_name: inflammatory breast carcinoma


subject: UNII:M89N0Q7EQR

object_name: Stage IIIB Breast Carcinoma


subject: UNII:M89N0Q7EQR

object_name: Anatomic Stage IIIB Breast Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: Prognostic Stage IIIB Breast Cancer AJCC v8


subject: UNII:M89N0Q7EQR

object_name: estrogen-receptor positive breast cancer


subject: UNII:M89N0Q7EQR

object_name: estrogen receptor-negative breast cancer


subject: UNII:M89N0Q7EQR

object_name: progesterone receptor-negative breast cancer


subject: UNII:M89N0Q7EQR

object_name: progesterone-receptor positive breast cancer


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: PR:000001379


subject: CHEBI:174615

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:174615

object_name: Carcinoma breast stage IV


subject: CHEBI:174615

object_name: Prognostic Stage IV Breast Cancer AJCC v8


subject: CHEBI:174615

object_name: Anatomic Stage IV Breast Cancer AJCC v8


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615

object_name: male breast carcinoma


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:174615


subject: CHEBI:28901

subject_name: Busulfan


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:28901


subject: CHEBI:82339

subject_name: Merphalan


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:82339


subject: CHEBI:28876

subject_name: Melphalan


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: CHEBI:28876


subject: UNII:5TAA004E22

subject_name: Sargramostim


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: UNII:5TAA004E22


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: PR:000005931


subject: CHEBI:9570

subject_name: Thiotepa


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:9570


subject: CHEBI:89324

subject_name: 24,25-Dihydroxyvitamin D

object_name: nephrolithiasis


subject: UMLS:C3714503

subject_name: Vitamin D Drug Class


subject: UNII:9VU1KI44GP

subject_name: VITAMIN D


subject: UMLS:C2936842

subject_name: Vitamin D [EPC]


subject: UMLS:C3537249

subject_name: D Vitamin


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: high grade B-cell lymphoma


subject: MESH:C571759

subject_name: R-CHOP protocol

object_name: adult lymphoma


subject: MESH:C571759

object_name: lymphoma


subject: MESH:C571759

object_name: pediatric lymphoma


subject: MESH:C571759

object_name: B-cell neoplasm


subject: CHEBI:2948

subject_name: Azathioprine

object_name: Chronic Kidney Disease, CTCAE


subject: UMLS:C5237476

subject_name: Rescue Medications

object_name: cervical cancer


subject: UMLS:C5237476

object_name: cervical carcinoma


subject: CHEBI:8485

subject_name: Proparacaine

object_name: retinopathy of prematurity


subject: CHEBI:8485

object_name: exudative vitreoretinopathy 1


subject: CHEBI:8485

object_name: Retinopathy of Prematurity, AE


subject: UniProtKB:Q86SI9

subject_name: CEI_HUMAN Putative uncharacterized protein IRX2-DT (sprot)

object_name: esophageal disorder


subject: CHEBI:90936

subject_name: Alectinib

object_name: liver carcinoma


subject: CHEMBL.COMPOUND:CHEMBL5314366

subject_name: ESOMEPRAZOLE MAGNESIUM

object_name: dyspepsia


subject: CHEMBL.COMPOUND:CHEMBL5314366

object_name: Dyspepsia, CTCAE


subject: PUBCHEM.COMPOUND:23724878

subject_name: dalbavancin

object_name: Staphylococcal bacteraemia


subject: PR:000004274

subject_name: ADP-ribosylation factor-like protein 10

object_name: malignant soft tissue neoplasm


subject: PR:000004274

object_name: sarcoma


subject: GTOPDB:13790

subject_name: benmelstobart

object_name: Childhood Breast Carcinoma


subject: GTOPDB:13790

object_name: breast carcinoma


subject: GTOPDB:13790

object_name: breast cancer


subject: UNII:B25CF42QKP

subject_name: BENMELSTOBART


subject: UNII:B25CF42QKP


subject: UNII:B25CF42QKP


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C5777125


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: UMLS:C4744993


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: nodular basal cell carcinoma


subject: PUBCHEM.COMPOUND:14907381

object_name: nevoid basal cell carcinoma syndrome


subject: CHEBI:190410

subject_name: 13-Demethyl tacrolimus


subject: CHEBI:190410


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:46345


subject: UMLS:C4048796


subject: UMLS:C4048796

object_name: skin neoplasm


subject: UNII:7JNY4KV3NK

subject_name: OCIPERLIMAB

object_name: relapsed/refractory diffuse large B-cell lymphoma


subject: UNII:7JNY4KV3NK

object_name: Diffuse large B-cell lymphoma recurrent


subject: UMLS:C5417829

subject_name: Ociperlimab


subject: UMLS:C5417829


subject: GTOPDB:9592

subject_name: tislelizumab


subject: GTOPDB:9592


subject: CHEMBL.COMPOUND:CHEMBL4297840

subject_name: TISLELIZUMAB


subject: CHEMBL.COMPOUND:CHEMBL4297840


subject: UMLS:C4053664


subject: UMLS:C4053664


subject: CHEBI:75929

object_name: Prostatitis category III (National Institute of Health classification)


subject: CHEBI:40009

subject_name: Cycloserine


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: autoimmune polyendocrinopathy


subject: UNII:4F4X42SYQ6

object_name: antiphospholipid syndrome


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: CHEBI:50634

object_name: Subarachnoid Hemorrhage, Aneurysmal


subject: CHEBI:50634

object_name: Cerebral Vasospasm


subject: CHEBI:27690

subject_name: Acetazolamide


subject: CHEBI:27690


subject: CHEBI:231679

subject_name: ipilimumab

object_name: Stage IIIB Uveal Melanoma AJCC v7


subject: CHEBI:231679

object_name: Stage IIIC Uveal Melanoma AJCC v7


subject: CHEBI:231679

object_name: Stage III Acral Lentiginous Melanoma AJCC v7


subject: CHEBI:231679

object_name: Stage IV Acral Lentiginous Melanoma AJCC v6 and v7


subject: CHEBI:231614

subject_name: Nivolumab


subject: CHEBI:231614


subject: CHEBI:231614


subject: CHEBI:231614


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UMLS:C2346820


subject: UNII:AF75XOF6W3

subject_name: Relatlimab

object_name: ocular melanoma


subject: UNII:AF75XOF6W3

object_name: uveal melanoma


subject: UNII:AF75XOF6W3

object_name: mucosal melanoma


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3

object_name: Stage IV Uveal Melanoma AJCC v7


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3

object_name: Stage IIIB Cutaneous Melanoma AJCC v7


subject: UNII:AF75XOF6W3

object_name: Stage IIIC Cutaneous Melanoma AJCC v7


subject: UNII:AF75XOF6W3

object_name: Stage IV Cutaneous Melanoma AJCC v6 and v7


subject: UNII:AF75XOF6W3


subject: UNII:AF75XOF6W3


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: UMLS:C3827149


subject: CHEBI:15966

subject_name: D-Glutamic Acid

object_name: malignant soft tissue neoplasm


subject: CHEBI:15966

object_name: sarcoma


subject: CHEBI:15966

object_name: leukemia


subject: CHEBI:15966

object_name: childhood leukemia


subject: CHEBI:15966

object_name: adult lymphoma


subject: CHEBI:15966

object_name: lymphoma


subject: CHEBI:15966

object_name: pediatric lymphoma


subject: CHEBI:15966

object_name: neurotoxicity


subject: CHEBI:15966

object_name: renal carcinoma


subject: CHEBI:15966

object_name: kidney neoplasm


subject: CHEBI:15966

object_name: kidney cancer


subject: CHEBI:15966

object_name: peripheral nervous system disorder


subject: CHEBI:15966

object_name: neuropathy


subject: CHEBI:16015

subject_name: Glutamic acid


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:16015


subject: CHEBI:73678

object_name: Surgical Wound Infection


subject: UMLS:C3180953

object_name: Depressed mood


subject: UMLS:C3180953

object_name: Cancer patients and suicide and depression


subject: UMLS:C3180953

object_name: Depressed - symptom


subject: UMLS:C3180953

object_name: Depression, CTCAE


subject: KEGG.COMPOUND:C00374

subject_name: Heparin

object_name: myocardial infarction


subject: KEGG.COMPOUND:C00374

object_name: Myocardial Infarction, CTCAE


subject: KEGG.COMPOUND:C00374

object_name: Myocardial Infarction by ECG Finding


subject: MESH:C547155

object_name: anterior uveitis


subject: CHEBI:90

subject_name: Epicatechin

object_name: Borderline hypertension


subject: CHEBI:15600

subject_name: Cianidanol


subject: CHEBI:135983

subject_name: Teriparatide

object_name: osteoarthritis, knee


subject: CHEBI:135983

object_name: Degenerative disorder of cartilage


subject: CHEBI:6129

subject_name: Ketorolac

object_name: Bilateral cataracts (disorder)


subject: CHEBI:75922

subject_name: Nepafenac


subject: CHEBI:41423

subject_name: Celecoxib

object_name: Crohn disease


subject: CHEBI:17553

object_name: Myalgia


subject: CHEBI:71464

subject_name: Palmidrol


subject: UMLS:C1572795

subject_name: PEA Preparation


subject: CHEBI:18397

subject_name: Phenethylamine


subject: DRUGBANK:DB10551

subject_name: Pea


subject: CHEBI:95043

object_name: colorectal cancer


subject: CHEBI:95043

object_name: colorectal carcinoma


subject: CHEBI:95043

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:31355

subject_name: Carboplatin

object_name: Stage IB Gastric Carcinoma


subject: CHEBI:31355

object_name: Malignant neoplasm of stomach stage II


subject: CHEBI:31355

object_name: Stage IIB Gastric Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIA Gastric Cancer AJCC v7


subject: CHEBI:31355

object_name: Stage IIIB Gastric Carcinoma


subject: CHEBI:31355

object_name: Stage IIIA Gastric Carcinoma


subject: PUBCHEM.COMPOUND:14907381

subject_name: Fluoruracil

object_name: gastric cardia adenocarcinoma


subject: CHEBI:46345

subject_name: Fluorouracil


subject: CHEBI:15640

subject_name: Leucovorin


subject: CHEBI:15640


subject: PUBCHEM.COMPOUND:43805

subject_name: Oxaliplatin


subject: UMLS:C1314429

subject_name: INJECTION, OXALIPLATIN, 0.5 MG ADMINISTERED


subject: CHEBI:45863

subject_name: Paclitaxel


subject: CHEBI:45863


subject: CHEBI:45863


subject: CHEBI:45863


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: CHEBI:4325

subject_name: Dapsone

object_name: Mycobacterium leprae infection


subject: CHEBI:7565

subject_name: Nifedipine

object_name: adrenogenital syndrome


subject: CHEBI:7565

object_name: congenital adrenal hyperplasia


subject: MESH:C000722356


subject: CHEBI:18332

subject_name: Levothyroxine

object_name: sarcopenia


subject: CHEBI:50853

subject_name: quantum dot

object_name: essential hypertension


subject: UMLS:C5853669

object_name: cytokine release syndrome


subject: UMLS:C5853669

object_name: Cytokine Release Syndrome, CTCAE


subject: MESH:C525022

subject_name: polyglutamate camptothecin

object_name: unspecified adult solid tumor, protocol specific


subject: CHEBI:28939

subject_name: Acetylcysteine

object_name: systemic sclerosis


subject: CHEBI:28939

object_name: diffuse scleroderma


subject: CHEBI:7421

subject_name: NAC


subject: CHEBI:7421


subject: CHEBI:91951

object_name: ovarian serous adenocarcinoma


subject: PUBCHEM.COMPOUND:17756771

subject_name: Fulvestrant


subject: CHEBI:68646

subject_name: REGORAFENIB


subject: CHEBI:68647

subject_name: Regorafenib


subject: DRUGBANK:DB19270

object_name: carcinoma of esophagus


subject: DRUGBANK:DB19270

object_name: esophageal cancer


subject: DRUGBANK:DB19270

object_name: Childhood Esophageal Carcinoma


subject: DRUGBANK:DB19270

object_name: neoplasm of esophagus


subject: UMLS:C2984517

subject_name: Saponin-based Immunoadjuvant OBI-821


subject: UMLS:C2984517


subject: UMLS:C2984517


subject: UMLS:C2984517


subject: CHEBI:66919

subject_name: Ruxolitinib

object_name: exanthem


subject: CHEBI:66919

object_name: Eruptions


subject: GTOPDB:7988

subject_name: nimotuzumab

object_name: Advanced cancer


subject: GTOPDB:7988

object_name: adrenocortical carcinoma, hereditary


subject: GTOPDB:7988

object_name: natural killer cell mediated immunity


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UNII:6NS400BXKH


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: UMLS:C1570308


subject: PUBCHEM.COMPOUND:3844471

subject_name: Irofulven

object_name: ovarian cancer


subject: PUBCHEM.COMPOUND:3844471

object_name: ovarian neoplasm


subject: PUBCHEM.COMPOUND:3844471

object_name: ovarian carcinoma


subject: PUBCHEM.COMPOUND:3844471

object_name: fallopian tube carcinoma


subject: PUBCHEM.COMPOUND:3844471

object_name: fallopian tube cancer


subject: UMLS:C4329342

subject_name: Anti-androgen siRNA SXL01

object_name: Prostatic Cancer, Castration-Resistant


subject: UNII:1C6V77QF41

subject_name: CHOLECALCIFEROL

object_name: st. Louis encephalitis


subject: CHEBI:35617

subject_name: flavouring agent

object_name: Nicotine Use Disorder


subject: CHEBI:74947

subject_name: Thalidomide


subject: CHEBI:6931

subject_name: Midazolam

object_name: vesicoureteral reflux


subject: CHEBI:6931

object_name: vesicoureteral reflux 1


subject: CHEBI:100241

subject_name: Ciprofloxacin

object_name: Dysbacteriosis


subject: CHEBI:151315

subject_name: Heparin

object_name: isolated splenic vein thrombosis


subject: UNII:E47C0NF7LV

subject_name: ENOXAPARIN


subject: UNII:8NZ41MIK1O

subject_name: Enoxaparin


subject: CHEBI:35526

subject_name: hypoglycemic agent

object_name: Diabetic peripheral neuropathy


subject: UMLS:C0020616

subject_name: Hypoglycemic Agents


subject: CHEBI:6801

subject_name: Metformin


subject: CHEBI:35679

subject_name: antilipemic drug


subject: CHEBI:87631

subject_name: statin


subject: CHEBI:9150

subject_name: Simvastatin


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Prevention problem


subject: UNII:BDP0YZR82B

object_name: resistant hypertension


subject: UNII:BDP0YZR82B

object_name: Hypertension resistant to conventional therapy


subject: CHEBI:142437

subject_name: lepirudin

object_name: lung cancer


subject: CHEBI:142437

object_name: lung neoplasm


subject: CHEBI:142437

object_name: lung carcinoma


subject: UMLS:C0919146

subject_name: INJECTION, LEPIRUDIN, 50 MG Administered


subject: UMLS:C0919146


subject: UMLS:C0919146


subject: MESH:C586519

subject_name: endocem

object_name: Irreversible pulpitis


subject: UMLS:C2987633

subject_name: Multikinase Inhibitor AT9283

object_name: leukemia


subject: UMLS:C2987633

object_name: childhood leukemia


subject: CHEBI:71028

subject_name: Carglumic acid

object_name: urea cycle disorder


subject: UMLS:C0067889

subject_name: carglumic acid


subject: UMLS:C0067889

object_name: carbamoyl phosphate synthetase I deficiency disease


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: rapid-onset childhood obesity-hypothalamic dysfunction-hypoventilation-autonomic dysregulation syndrome


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:63660

object_name: Heart Failure, CTCAE


subject: CHEBI:63618

subject_name: Pravastatin


subject: UNII:UC95NQ339C

subject_name: BOTULINUM TOXIN

object_name: Presenile dementia


subject: UNII:UC95NQ339C

object_name: dementia


subject: UNII:UC95NQ339C

object_name: Gegenhalten


subject: UMLS:C0006055

subject_name: Botulinum Toxins


subject: UMLS:C0006055


subject: UMLS:C0006055


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Recurrent High Risk Myelodysplastic Syndrome


subject: PUBCHEM.COMPOUND:1805

object_name: Refractory High Risk Myelodysplastic Syndrome


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:2038


subject: CHEBI:145374

subject_name: Enasidenib

object_name: myelodysplastic syndrome with excess blasts


subject: CHEBI:145374


subject: CHEBI:145374


subject: CHEBI:145374

object_name: Blasts 20-30 Percent of Bone Marrow Nucleated Cells


subject: CHEBI:17045

subject_name: Nitrous oxide

object_name: Tinnitus


subject: CHEBI:17045

object_name: Tinnitus, CTCAE 5.0


subject: CHEBI:17045

object_name: Tinnitus, CTCAE 3.0


subject: PUBCHEM.COMPOUND:3084049

subject_name: hyaluronan

object_name: osteoarthritis, knee


subject: CHEBI:132153

subject_name: hyaluronate


subject: PUBCHEM.COMPOUND:18319735

subject_name: Mirabegron

object_name: Urinary Frequency or Urgency, CTCAE


subject: PUBCHEM.COMPOUND:18319735

object_name: Painful Bladder Syndrome


subject: PUBCHEM.COMPOUND:18319735

object_name: Detrusor instability


subject: PUBCHEM.COMPOUND:18319735

object_name: multiple sclerosis


subject: CHEBI:83766

subject_name: Olaparib

object_name: peritoneal neoplasm


subject: CHEBI:27082

subject_name: trehalose

object_name: Parkinson disease


subject: UMLS:C1725733

subject_name: ACB (Acebutolol)

object_name: Arthritis of knee


subject: UMLS:C1725733

object_name: knee pain chronic


subject: UMLS:C1725733


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: complex regional pain syndrome


subject: CHEBI:74705

subject_name: Met-Leu


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000016318

subject_name: thrombopoietin


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations

object_name: acute aortic dissection


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: CHEBI:48843

subject_name: sodium selenite

object_name: prostate carcinoma


subject: CHEBI:48843

object_name: prostate cancer


subject: CHEMBL.COMPOUND:CHEMBL1200571

subject_name: GADOBENATE DIMEGLUMINE

object_name: coronary artery disorder


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: coronary atherosclerosis


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: atrial fibrillation


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Atrial Fibrillation by ECG Finding


subject: CHEMBL.COMPOUND:CHEMBL1200571

object_name: Atrial Fibrillation, CTCAE


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UNII:3Q6PPC19PO


subject: UMLS:C1508867

subject_name: MYCOPHENOLIC ACID, ORAL, 180 MG ADMINISTERED

object_name: nephrotic syndrome


subject: UMLS:C1508867

object_name: Nephrotic Syndrome, CTCAE


subject: UNII:DQY244459T

object_name: cocaine use disorder


subject: UMLS:C4086546

subject_name: Liposomal Bupivacaine

object_name: chronic pain (diagnosis)


subject: UMLS:C4086546

object_name: Chronic pain


subject: CHEBI:175901

subject_name: Gemcitabine

object_name: Stage IV Nasopharyngeal Carcinoma AJCC v7


subject: UMLS:C1541153

subject_name: TOCOSOL™ Paclitaxel

object_name: transitional cell carcinoma


subject: UMLS:C1541153

object_name: urethra neoplasm


subject: UMLS:C1541153

object_name: ureter cancer


subject: UMLS:C1541153

object_name: ureter neoplasm


subject: UMLS:C1541153

object_name: bladder tumor


subject: CHEBI:16581

subject_name: Pregnenolone

object_name: Alcoholic Intoxication


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Surgical wound


subject: CHEBI:94518

object_name: Surgical wound finding


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: long COVID-19


subject: CHEMBL.COMPOUND:CHEMBL256907

subject_name: maraviroc


subject: CHEBI:41879

subject_name: Dexamethasone

object_name: Ann Arbor Stage I Grade 1 Follicular Lymphoma


subject: CHEBI:41879

object_name: Ann Arbor Stage I Grade 2 Follicular Lymphoma


subject: CHEBI:41879

object_name: Ann Arbor Stage IV Grade 2 Follicular Lymphoma


subject: CHEBI:41879

object_name: Ann Arbor Stage IV Grade 1 Follicular Lymphoma


subject: CHEBI:41879

object_name: Ann Arbor Stage III Grade 1 Follicular Lymphoma


subject: CHEBI:41879

object_name: Ann Arbor Stage III Grade 2 Follicular Lymphoma


subject: CHEBI:41879

object_name: Ann Arbor Stage II Grade 1 Contiguous Follicular Lymphoma


subject: CHEBI:41879

object_name: Ann Arbor Stage II Grade 2 Contiguous Follicular Lymphoma


subject: CHEBI:41879

object_name: Ann Arbor Stage II Grade 1 Non-Contiguous Follicular Lymphoma


subject: CHEBI:41879

object_name: Ann Arbor Stage II Grade 2 Non-Contiguous Follicular Lymphoma


subject: CHEBI:41879

object_name: Marginal zone lymphoma stage I


subject: CHEBI:41879

object_name: Marginal zone lymphoma stage III


subject: CHEBI:41879

object_name: Marginal zone lymphoma stage IV


subject: CHEBI:2965

object_name: Pulmonary Hypertension, CTCAE


subject: UMLS:C0379142


subject: MESH:D013607

subject_name: Tablets

object_name: Atopic rhinitis


subject: MESH:D013607

object_name: Allergic Rhinitis, CTCAE


subject: UNII:O880NM097T

subject_name: Avacopan

object_name: granulomatosis with polyangiitis


subject: CHEBI:63631

subject_name: Topiramate

object_name: epilepsy with generalized tonic-clonic seizures


subject: UNII:2XLN4Y044H

subject_name: REGADENOSON

object_name: cold agglutinin disease


subject: UNII:2XLN4Y044H

object_name: congenital alveolar dysplasia


subject: UNII:2XLN4Y044H

object_name: autoimmune hemolytic anemia, cold type


subject: PUBCHEM.COMPOUND:22451303

subject_name: Regadenoson


subject: PUBCHEM.COMPOUND:22451303


subject: PUBCHEM.COMPOUND:22451303


subject: CHEBI:4903

subject_name: Ethinylestradiol

object_name: thrombophilia due to thrombin defect


subject: CHEBI:4903

object_name: Venous thrombosis after immobility


subject: UNII:UM2XKY25DH

subject_name: NORELGESTROMIN


subject: UNII:UM2XKY25DH


subject: CHEBI:50815

subject_name: Norgestimate


subject: CHEBI:50815


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Vulvar Vestibulitis


subject: CHEBI:66910

subject_name: Axitinib

object_name: collecting duct carcinoma


subject: UMLS:C3197669

subject_name: Perflutren Lipid Microsphere Intravenous Suspension

object_name: prostate cancer


subject: UMLS:C3197669

object_name: prostate neoplasm


subject: CHEBI:7852

subject_name: Oxycodone

object_name: osteoarthritis, knee


subject: CHEBI:7852

object_name: osteoarthritis, hip


subject: CHEBI:35610

subject_name: antineoplastic agent

object_name: metastatic colorectal cancer


subject: CHEBI:31859

subject_name: Modafinil

object_name: neurobehavioral manifestations


subject: CHEBI:36791

subject_name: Escitalopram

object_name: myocardial ischemia


subject: CHEBI:3723

subject_name: Citalopram


subject: MESH:C011499

subject_name: methanol extraction residue (MER) tubercle bacillus fraction

object_name: malignant histiocytosis


subject: MESH:C011499

object_name: bone fibrosarcoma


subject: MESH:C011499

object_name: hematopoietic and lymphoid system neoplasm


subject: MESH:C011499

object_name: primary central nervous system lymphoma


subject: MESH:C011499

object_name: B-cell small lymphocytic lymphoma refractory


subject: MESH:C011499

object_name: B-cell small lymphocytic lymphoma recurrent


subject: MESH:C011499

object_name: Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: MESH:C011499

object_name: Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm


subject: MESH:C011499

object_name: Follicular lymphoma refractory


subject: MESH:C011499

object_name: Refractory Langerhans Cell Histiocytosis


subject: MESH:C011499

object_name: primary cutaneous peripheral T-cell lymphoma not otherwise specified


subject: MESH:C011499

object_name: peripheral T-cell lymphoma, not otherwise specified


subject: MESH:C011499

object_name: Recurrent Langerhans Cell Histiocytosis


subject: MESH:C011499

object_name: Refractory Chronic Myelomonocytic Leukemia


subject: MESH:C011499

object_name: Follicular lymphoma recurrent


subject: MESH:C011499


subject: MESH:C011499

object_name: Recurrent Chronic Myelomonocytic Leukemia


subject: MESH:C011499

object_name: primary cutaneous T-cell non-Hodgkin lymphoma


subject: MESH:C011499

object_name: primary cutaneous T-cell lymphoma


subject: MESH:C011499

object_name: Chronic lymphocytic leukaemia refractory


subject: MESH:C011499

object_name: Refractory Myelodysplastic Syndrome


subject: MESH:C011499

object_name: Recurrent Chronic Lymphoid Leukemia


subject: MESH:C011499

object_name: Refractory Erdheim-Chester Disease


subject: MESH:C011499

object_name: Recurrent Myelodysplastic Syndrome


subject: MESH:C011499

object_name: Recurrent Acute Myeloid Leukemia with Myelodysplasia-Related Changes


subject: MESH:C011499

object_name: Refractory Myelofibrosis


subject: MESH:C011499

object_name: sinus histiocytosis with massive lymphadenopathy


subject: MESH:C011499

object_name: Recurrent Myelofibrosis


subject: MESH:C011499

object_name: histiocytic sarcoma


subject: CHEBI:142432

subject_name: Vericiguat

object_name: Complication of hemodialysis


subject: UMLS:C5204486

subject_name: Imsapepimut

object_name: non-small cell lung carcinoma


subject: UNII:5CIT1X6U5V

subject_name: MELON

object_name: skin disorder


subject: UMLS:C3256061

subject_name: melon extract


subject: CHEBI:45863

subject_name: Paclitaxel

object_name: prostate neoplasm


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: cancer


subject: PUBCHEM.COMPOUND:3367

object_name: glioma


subject: PUBCHEM.COMPOUND:3367

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:63599

subject_name: Fludarabine


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab

object_name: Adult Meningioma


subject: UNII:DPT0O3T46P

object_name: benign meningioma


subject: UNII:DPT0O3T46P

object_name: familial meningioma


subject: UNII:DPT0O3T46P

object_name: pediatric meningioma


subject: UNII:DPT0O3T46P

object_name: meningioma


subject: PR:000001151

subject_name: Toll-like receptor 1

object_name: brain cancer


subject: PR:000001151

object_name: brain neoplasm


subject: PR:000001151


subject: PR:000001151


subject: PR:000001151


subject: PR:000001151


subject: PR:000001151


subject: PR:000001151


subject: PR:000001151

object_name: Childhood Glioblastoma


subject: CHEBI:86345

subject_name: magnesium dichloride hexahydrate

object_name: Hypomagnesemia


subject: CHEBI:86345

object_name: Hypomagnesemia, CTCAE


subject: CHEBI:86345

object_name: hypertension


subject: CHEBI:86345

object_name: diabetes mellitus


subject: PUBCHEM.COMPOUND:1805

subject_name: Azacytidine, 5-

object_name: Recurrent Brain Neoplasm


subject: CHEBI:2038

subject_name: Azacitidine


subject: CHEBI:23359

subject_name: colchicine

object_name: aphthous stomatitis


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:28918

subject_name: Epinephrine

object_name: Epistaxis


subject: CHEBI:31515

subject_name: Domperidone

object_name: Breastfeeding (mother)


subject: CHEBI:3441

subject_name: Carvedilol

object_name: cocaine dependence


subject: CHEBI:3441

object_name: opiate dependence


subject: CHEBI:66964

subject_name: Dronabinol

object_name: Skin-picking


subject: CHEBI:63631

subject_name: Topiramate

object_name: cannabis abuse


subject: UMLS:C4705566

object_name: Back Pain, CTCAE 5.0


subject: UMLS:C4705566

object_name: Back pain


subject: UMLS:C4705566

object_name: Back Pain, CTCAE 3.0


subject: UMLS:C5226792


subject: UMLS:C5226792


subject: UMLS:C5226792


subject: CHEMBL.COMPOUND:CHEMBL4297908

subject_name: CEVOSTAMAB

object_name: Relapsed/refractory multiple myeloma


subject: UMLS:C4528565


subject: UMLS:C2718449

subject_name: CARALLUMA FIMBRIATA extract

object_name: Stress


subject: PUBCHEM.COMPOUND:46874763

object_name: bacteriuria


subject: PUBCHEM.COMPOUND:46874763

object_name: Asymptomatic Infections


subject: PUBCHEM.COMPOUND:46874763

object_name: transplantation infection


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C0003232


subject: CHEBI:86345

object_name: stroke disorder


subject: CHEBI:86345

object_name: cerebrovascular disorder


subject: CHEBI:86345

object_name: Stroke (heart beat)


subject: CHEBI:86345

object_name: Stroke, CTCAE


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:25107


subject: CHEBI:7563

subject_name: N-nicotinoylglycine

object_name: Androgen excess


subject: MESH:D009539

subject_name: Nicotinic Acids


subject: UMLS:C3714626

subject_name: Nicotinic Acid Drug Class


subject: CHEBI:15940

subject_name: Niacin


subject: UMLS:C3536880

subject_name: Nicotinic Acid [EPC]


subject: CHEBI:135942

subject_name: Laropiprant


subject: PUBCHEM.COMPOUND:10216733

subject_name: DIASTEREOMER 2


subject: UMLS:C2012335

subject_name: goserelin acetate implant

object_name: abdominal obesity-metabolic syndrome


subject: UMLS:C2012335

object_name: metabolic syndrome X


subject: UMLS:C0499132

subject_name: GOSERELIN ACETATE IMPLANT, PER 3.6 MG


subject: UMLS:C0499132


subject: UNII:Q8L6AN59YY

subject_name: Bitopertin

object_name: beta thalassemia


subject: UNII:Q8L6AN59YY

object_name: beta-thalassemia HBB/LCRB


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Necrosis caused by ionizing radiation


subject: CHEBI:50858

subject_name: corticosteroid

object_name: metastatic malignant neoplasm in the brain


subject: CHEBI:50858


subject: MESH:D000305

subject_name: Adrenal Cortex Hormones


subject: MESH:D000305


subject: UMLS:C3540725

subject_name: Corticosteroid otologicals


subject: UMLS:C3540725


subject: UMLS:C3539185

subject_name: Corticosteroid nasal preparations for topical use


subject: UMLS:C3539185


subject: UMLS:C3540726

subject_name: Corticosteroid ophthalmologic and otologic preparations


subject: UMLS:C3540726


subject: UMLS:C3540727

subject_name: Corticosteroids, topical for treatment of hemorrhoids and anal fissures


subject: UMLS:C3540727


subject: UMLS:C3540792

subject_name: Magnesium supplements, alimentary tract and metabolism

object_name: magnesium measurement


subject: CHEBI:25107

subject_name: magnesium atom


subject: CHEBI:18420


subject: UMLS:C3714621

subject_name: Magnesium Drug Class


subject: CHEBI:44915

subject_name: Propofol

object_name: cancer recurrence


subject: CHEBI:9130

subject_name: Sevoflurane


subject: UNII:4F4X42SYQ6

subject_name: Rituximab

object_name: immunotactoid glomerulopathy


subject: UNII:4F4X42SYQ6

object_name: non-amyloid fibrillary glomerulopathy


subject: UMLS:C0295415

subject_name: rituximab


subject: UMLS:C0295415


subject: UMLS:C0034862

subject_name: Vaccines, Recombinant

object_name: HPV-related carcinoma


subject: UMLS:C0034862

object_name: Anal Intraepithelial Neoplasia 2


subject: UMLS:C0034862

object_name: Low Grade Anal Intraepithelial Neoplasia


subject: UMLS:C0034862

object_name: anal canal carcinoma in situ


subject: UMLS:C0034862

object_name: Low Grade Prostatic Intraepithelial Neoplasia


subject: CHEBI:10023

subject_name: Voriconazole

object_name: Immunocompromised Host


subject: MESH:D002214

subject_name: Capsules

object_name: Drug Interactions


subject: CHEBI:30742

subject_name: macrogol

object_name: Nerve injury


subject: UNII:2EWN8Z05CN

subject_name: Zotatifin

object_name: Coronavinae infectious disease


subject: CHEBI:4636

subject_name: Diphenhydramine

object_name: acute liver failure


subject: CHEBI:4636

object_name: Acute liver injury


subject: CHEBI:4636

object_name: Immune dysregulation


subject: CHEBI:4636

object_name: Fulminant hepatic failure


subject: CHEBI:4636

object_name: hepatic encephalopathy


subject: UMLS:C0004149

subject_name: ATGAM


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: UMLS:C0004149


subject: CHEBI:6888

subject_name: Methylprednisolone


subject: CHEBI:6888


subject: CHEBI:6888


subject: CHEBI:8378

subject_name: Prednisolone


subject: CHEBI:8378


subject: CHEBI:8378


subject: CHEBI:231324

subject_name: alpelisib

object_name: Premenopausal breast cancer


subject: UMLS:C2986399


subject: CHEBI:71954

subject_name: Buparlisib


subject: UNII:16VY3TM7ZO

subject_name: Antineoplaston A10

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v7


subject: UNII:16VY3TM7ZO

object_name: Stage IV Adrenal Cortex Carcinoma AJCC v8


subject: UMLS:C4721487

subject_name: ATENGENAL


subject: UMLS:C4721487


subject: UMLS:C4721495

subject_name: Astugenal


subject: UMLS:C4721495


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: ureter transitional cell carcinoma


subject: UNII:DLE8519RWM

object_name: urethra transitional cell carcinoma


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C2346820

object_name: renal pelvis/ureter urothelial carcinoma


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:CWG62Q1VTB

subject_name: Sitravatinib

object_name: urothelial carcinoma


subject: UNII:CWG62Q1VTB

object_name: transitional cell carcinoma


subject: UNII:CWG62Q1VTB


subject: UNII:CWG62Q1VTB


subject: UNII:CWG62Q1VTB


subject: UMLS:C2985197

object_name: non-Hodgkin lymphoma


subject: PUBCHEM.COMPOUND:18541918

subject_name: Ampicillin-sulbactam

object_name: thoracic aortic aneurysm


subject: PUBCHEM.COMPOUND:18541918

object_name: Thoracic aortic aneurysm without rupture


subject: PUBCHEM.COMPOUND:18541918

object_name: Dissection, Thoracic Aorta


subject: PUBCHEM.COMPOUND:18541918

object_name: heart valve disorder


subject: PUBCHEM.COMPOUND:18541918

object_name: Dissecting aortic aneurysm


subject: CHEBI:51770

subject_name: Sultamicillin


subject: CHEBI:51770


subject: CHEBI:51770


subject: CHEBI:51770


subject: CHEBI:51770


subject: CHEBI:144094

subject_name: bicalutamide

object_name: Coronavinae infectious disease


subject: CHEBI:144094

object_name: severe acute respiratory syndrome


subject: GTOPDB:6749

subject_name: fibrinogen

object_name: heart disorder


subject: KEGG.COMPOUND:C00393

subject_name: Fibrinogen


subject: UMLS:C3540039

subject_name: Fibrinogen containing hemostatics


subject: UMLS:C2587184

subject_name: Parenogen


subject: UMLS:C0016006


subject: UMLS:C3541956

subject_name: prothrombin complex


subject: UMLS:C0072434

subject_name: prothrombin complex concentrates


subject: CHEBI:5181

subject_name: fucoidan

object_name: Cachexia


subject: CHEBI:8382

subject_name: Prednisone

object_name: osteoarthritis


subject: CHEBI:474053

subject_name: Cefazolin

object_name: Bacteremia caused by Staphylococcus aureus


subject: CHEBI:3745

subject_name: clindamycin


subject: CHEBI:179553

subject_name: Hexyl 2-methylpropanoate


subject: CHEBI:17334

subject_name: penicillin


subject: CHEBI:76842


subject: CHEBI:28001

subject_name: Vancomycin


subject: UNII:29L5I58185

subject_name: Lithium gluconate

object_name: Canavan disease


subject: UNII:29L5I58185

object_name: malnutrition


subject: UMLS:C0126000

subject_name: lithium gluconate


subject: UMLS:C0126000


subject: CHEBI:33198

subject_name: Gluconic Acid


subject: CHEBI:33198


subject: UMLS:C0013227

subject_name: Pharmaceutical Preparations


subject: UMLS:C0013227


subject: UMLS:C1254351

subject_name: Pharmacologic Substance


subject: UMLS:C1254351


subject: PUBCHEM.COMPOUND:23664049

subject_name: SODIUM GLUCONATE


subject: PUBCHEM.COMPOUND:23664049


subject: UMLS:C4725693

subject_name: FGFR1/2/3 Inhibitor HMPL-453

object_name: malignant mesothelioma


subject: CHEMBL.COMPOUND:CHEMBL4650297


subject: DRUGBANK:DB16369

subject_name: Matrix-M

object_name: Plasmodium falciparum malaria


subject: PUBCHEM.COMPOUND:3367

object_name: De Novo Myelodysplastic Syndrome


subject: UNII:MS6LGW5JFK

subject_name: Ezurpimtrostat

object_name: liver carcinoma


subject: DRUGBANK:DB19014

subject_name: Imdusiran

object_name: hepatitis B


subject: MESH:C557119

subject_name: NicVAX

object_name: nicotine dependence


subject: CHEBI:140115

subject_name: nicotine bitartrate


subject: UMLS:C2954800

subject_name: nicotine bitartrate anhydrous


subject: CHEBI:44915

subject_name: Propofol

object_name: Seizure Related to COVID-19


subject: CHEBI:44915

object_name: visual epilepsy


subject: CHEBI:44915

object_name: neoplasm of cerebral hemisphere


subject: CHEBI:6149

subject_name: Levobupivacaine

object_name: Musculoskeletal Pain


subject: CHEBI:6149

object_name: Neck Carcinoma


subject: CHEBI:6149

object_name: head and neck neoplasm


subject: CHEBI:6149

object_name: head and neck cancer


subject: CHEBI:67272

subject_name: Perifosine

object_name: prostate carcinoma


subject: CHEBI:67272

object_name: prostate cancer


subject: UMLS:C3540708

subject_name: Antibiotics, Gynecological

object_name: acute kidney failure


subject: UMLS:C3540708

object_name: Acute Kidney Injury, CTCAE


subject: MESH:D000904

subject_name: Antibiotics, Antitubercular


subject: MESH:D000904


subject: UMLS:C3540709

subject_name: antibiotics, intestinal


subject: UMLS:C3540709


subject: UMLS:C3540707

subject_name: Antibiotics FOR TREATMENT OF HEMORRHOIDS AND ANAL FISSURES FOR TOPICAL USE


subject: UMLS:C3540707


subject: UMLS:C0003232

subject_name: Antibiotics


subject: UMLS:C0003232


subject: UMLS:C3540704

subject_name: Antibiotics for systemic use


subject: UMLS:C3540704


subject: UMLS:C3540706

subject_name: Antibiotic throat preparations


subject: UMLS:C3540706


subject: UMLS:C3540710

subject_name: Antibiotics, ophthalmologic


subject: UMLS:C3540710


subject: UMLS:C3540705

subject_name: Antifungal Antibiotics, Topical


subject: UMLS:C3540705


subject: PUBCHEM.COMPOUND:90488848

object_name: abdominal aortic aneurysm


subject: CHEBI:3892

subject_name: Corticotropin


subject: CHEBI:174348

object_name: diabetes mellitus


subject: CHEBI:6717

subject_name: Mefenamic acid


subject: CHEBI:26710

subject_name: Sodium chloride

object_name: Ischemic stroke


subject: CHEBI:2948

subject_name: Azathioprine

object_name: sickle cell disease


subject: CHEBI:38545

subject_name: Rosuvastatin

object_name: colorectal cancer


subject: CHEBI:38545

object_name: colorectal carcinoma


subject: CHEBI:38545

object_name: Malignant neoplasm of cecum and/or colon and/or rectum (disorder)


subject: CHEBI:38545

object_name: precancerous condition


subject: CHEBI:39548

subject_name: Atorvastatin

object_name: Alzheimer disease type 1


subject: UNII:I031V2H011

subject_name: Tocilizumab

object_name: Antibody-mediated rejection


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: ISS Stage III Plasma Cell Myeloma


subject: CHEBI:95021

subject_name: pemetrexed

object_name: Teeth, Endodontically-Treated


subject: CHEBI:95021

object_name: dental pulp disorder


subject: CHEBI:17509


subject: CHEBI:17509


subject: PUBCHEM.COMPOUND:23279496

subject_name: uridine triacetate

object_name: orotic aciduria


subject: PUBCHEM.COMPOUND:254731


subject: CHEBI:8382

subject_name: Prednisone

object_name: Pneumonia caused by SARS-CoV-2


subject: CHEBI:3127

subject_name: Bisoprolol

object_name: Heart failure with reduced ejection fraction


subject: CHEBI:6904

subject_name: Metoprolol


subject: CHEBI:64019

subject_name: Nebivolol


subject: CHEBI:64019

object_name: cardiovascular disorder


subject: CHEBI:232048

object_name: non-small cell lung carcinoma


subject: UMLS:C2985180

subject_name: Debio 0932


subject: CHEBI:17754

subject_name: Glycerin

object_name: Antioxidative Stress


subject: CHEBI:17754

object_name: Hyperlactatemia


subject: CHEBI:17754

object_name: performance enhancing product use


subject: CHEBI:17754

object_name: Weight Change


subject: CHEBI:17754

object_name: Thermal Sensation Disorders


subject: CHEBI:17754

object_name: Abnormality of temperature regulation


subject: CHEBI:63791

subject_name: Lenalidomide

object_name: nonpapillary renal cell carcinoma


subject: CHEBI:63791

object_name: clear cell renal carcinoma


subject: CHEBI:63791

object_name: renal cell adenocarcinoma


subject: CHEBI:63791

object_name: renal cell carcinoma


subject: UMLS:C2699534

subject_name: Cyclosporine Ophthalmic Emulsion

object_name: graft versus host disease


subject: UMLS:C2699534

object_name: myeloproliferative neoplasm


subject: UMLS:C2699534


subject: UMLS:C2699534

object_name: Myelodysplasia


subject: UMLS:C2699534

object_name: leukemia


subject: UMLS:C2699534

object_name: childhood leukemia


subject: UMLS:C2699534

object_name: adult lymphoma


subject: UMLS:C2699534

object_name: lymphoma


subject: UMLS:C2699534

object_name: pediatric lymphoma


subject: CHEBI:94573

subject_name: Zibotentan

object_name: Carcinoma breast stage IV


subject: UMLS:C5854316

subject_name: Oozfix

object_name: gastric neoplasm


subject: UMLS:C3831603

object_name: malignant glioma


subject: UMLS:C3831603

object_name: glioblastoma


subject: UMLS:C3831603

object_name: Brain Stem Glioblastoma


subject: UMLS:C3831603

object_name: glioma susceptibility 1


subject: UniProtKB:P47737

subject_name: X19F_ECOLI X polypeptide (sprot)

object_name: Transformed Follicular Lymphoma to Diffuse Large B-Cell Lymphoma


subject: UniProtKB:P47737

object_name: diffuse large B-cell lymphoma


subject: UniProtKB:P47737

object_name: Waldenstrom macroglobulinemia


subject: UniProtKB:P47737

object_name: B-cell chronic lymphocytic leukemia


subject: UniProtKB:P47737

object_name: Indolent Non-Hodgkin Lymphoma


subject: UniProtKB:P47737

object_name: Indolent Adult Non-Hodgkin Lymphoma


subject: UniProtKB:P47737

object_name: marginal zone lymphoma


subject: UniProtKB:P47737

object_name: MALT lymphoma


subject: UniProtKB:P47737

object_name: primary central nervous system lymphoma


subject: UniProtKB:P47737

object_name: Burkitt lymphoma


subject: CHEBI:35430

subject_name: DIIODOTHYRONINE


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:35430


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:75710


subject: CHEBI:29298

subject_name: ditritium


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: CHEBI:29298


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: PR:000003610


subject: UniProtKB:Q06666

subject_name: T2_MOUSE Octapeptide-repeat protein T2 (sprot)


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: UniProtKB:Q06666


subject: PR:000034234

subject_name: octapeptide-repeat protein T2


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: PR:000034234


subject: RXCUI:2648470

subject_name: mometasone furoate Nasal Spray


subject: RXCUI:2648470

object_name: anosmia


subject: RXCUI:2648470

object_name: Anosmia, CTCAE


subject: UMLS:C5417815

subject_name: PARP7 Inhibitor RBN-2397

object_name: Adult Solid Neoplasm


subject: CHEBI:135915

subject_name: Thymalfasin

object_name: hematopoietic and lymphoid system neoplasm


subject: PR:000015454

subject_name: sperm-associated antigen 11B

object_name: Menopausal syndrome


subject: PR:000022039

subject_name: dihydrolipoyllysine-residue acetyltransferase component of pyruvate dehydrogenase complex


subject: PR:000015453

subject_name: sperm-associated antigen 11A


subject: PR:000007260

subject_name: exosome complex component RRP40


subject: CHEBI:6129

subject_name: Ketorolac

object_name: appendicitis


subject: CHEBI:6129

object_name: Appendicitis, CTCAE


subject: CHEBI:74705

subject_name: Met-Leu


subject: CHEBI:74705


subject: CHEBI:74705

object_name: Abdominal pain


subject: CHEBI:74705

object_name: Abdominal Pain, CTCAE


subject: CHEBI:74705

object_name: Emergencies


subject: PR:000009425

subject_name: killer cell lectin-like receptor subfamily F member 1


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000009425


subject: PR:000016318

subject_name: thrombopoietin


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: PR:000016318


subject: UNII:6897GXD6OE

object_name: peripheral arterial disease


subject: UNII:638KY4573I

object_name: heart failure


subject: UNII:638KY4573I

object_name: Heart Failure, CTCAE


subject: PUBCHEM.COMPOUND:139350422

subject_name: Zanzalintinib

object_name: Unresectable Leiomyosarcoma


subject: PUBCHEM.COMPOUND:139350422

object_name: Metastatic leiomyosarcoma


subject: UNII:KC2JC2ZA04

subject_name: ZANZALINTINIB


subject: UNII:KC2JC2ZA04


subject: UNII:4Z63YK6E0E

subject_name: Daratumumab

object_name: Immunoglobulin deposition disease


subject: UNII:4Z63YK6E0E

object_name: Light chain (AL) amyloidosis


subject: CHEBI:41879

subject_name: Dexamethasone


subject: CHEBI:133021

subject_name: Venetoclax


subject: CHEBI:3215

subject_name: Bupivacaine

object_name: Regional anesthesia morbidity


subject: CHEBI:60802

subject_name: ropivacaine


subject: CHEBI:229221

subject_name: Fruquintinib

object_name: Metastatic non-small cell lung cancer


subject: UMLS:C4724859

subject_name: Geptanolimab


subject: UMLS:C5960312

subject_name: TLR7/8 Agonist INI-4001

object_name: Advanced Malignant Solid Neoplasm


subject: UNII:OWK8BG0FO6

object_name: Her2-receptor negative breast cancer


subject: UNII:OWK8BG0FO6

object_name: Carcinoma breast stage IV


subject: UMLS:C4725831

subject_name: Anti-CD40 Agonist Monoclonal Antibody CDX-1140


subject: UMLS:C4725831


subject: CHEMBL.COMPOUND:CHEMBL4650387


subject: CHEMBL.COMPOUND:CHEMBL4650387


subject: UMLS:C0935953

subject_name: Mobist


subject: UNII:UCG949AA7Z

subject_name: ADAGLOXAD SIMOLENIN

object_name: liver carcinoma


subject: UMLS:C2984517

subject_name: Saponin-based Immunoadjuvant OBI-821


subject: CHEBI:50733

subject_name: nutraceutical

object_name: relapsing-remitting multiple sclerosis


subject: CHEBI:41774

subject_name: Tamoxifen

object_name: endometrium carcinoma in situ


subject: CHEBI:41774

object_name: endometrial cancer


subject: GTOPDB:9758

subject_name: camrelizumab

object_name: Small cell lung cancer extensive stage


subject: UNII:73096E137E


subject: CHEBI:135765

subject_name: Methylprednisolone hemisuccinate

object_name: severe acute respiratory syndrome


subject: CHEBI:135765

object_name: severe acute respiratory syndrome (SARS) pneumonia


subject: CHEBI:169833

subject_name: Deacetyldiltiazem

object_name: atrial fibrillation new onset


subject: CHEBI:169833

object_name: paroxysmal atrial fibrillation


subject: CHEBI:82814

subject_name: Dilacor XR


subject: CHEBI:82814


subject: CHEBI:101278

subject_name: Diltiazem


subject: CHEBI:101278


subject: CHEBI:4856

subject_name: Esmolol


subject: CHEBI:4856


subject: CHEBI:25187

subject_name: Menthol

object_name: Dysphagia


subject: UMLS:C0009053

subject_name: collagenase Clostridium histolyticum

object_name: urethral stricture


subject: UMLS:C0009053

object_name: Urethral stricture


subject: UNII:SQ8A3S5101

subject_name: Fostamatinib

object_name: acute respiratory distress syndrome


subject: UNII:SQ8A3S5101

object_name: adult acute respiratory distress syndrome


subject: UNII:SQ8A3S5101

object_name: familial acute respiratory distress syndrome, ANLN-related, dog


subject: UNII:SQ8A3S5101

object_name: COVID-19-Associated Acute Respiratory Distress Syndrome


subject: UNII:DLE8519RWM

subject_name: ENFORTUMAB

object_name: Refractory Bladder Urothelial Carcinoma


subject: UNII:DLE8519RWM

object_name: Stage IV Bladder Cancer AJCC v7


subject: UNII:DLE8519RWM

object_name: Stage IV Renal Pelvis and Ureter Cancer AJCC v7


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UMLS:C3896914


subject: UNII:DPT0O3T46P

subject_name: Pembrolizumab


subject: UNII:DPT0O3T46P


subject: GTOPDB:10197

subject_name: vantictumab

object_name: Carcinoma breast stage IV


subject: UNII:88WBI2D80S

subject_name: VANTICTUMAB


subject: UMLS:C3273041

subject_name: Vantictumab


subject: UNII:2S9ZZM9Q9V

subject_name: Bevacizumab

object_name: Erdheim-Chester disease


subject: UNII:2S9ZZM9Q9V

object_name: Castleman disease


subject: UNII:2S9ZZM9Q9V

object_name: malignant urinary system neoplasm


subject: UNII:2S9ZZM9Q9V

object_name: digestive system carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: male reproductive organ cancer


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Digestive System Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Male Reproductive System Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Female Reproductive System Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: thoracic cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVA Pharyngeal Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:2S9ZZM9Q9V

object_name: respiratory system cancer


subject: UNII:2S9ZZM9Q9V

object_name: Stage IV Pharynx Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage III Pharynx Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVB Pharyngeal Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Stage IVC Pharyngeal Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: lip and oral cavity carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Thyroid Carcinoma


subject: UNII:2S9ZZM9Q9V

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: UNII:2S9ZZM9Q9V

object_name: Pharyngeal cancer recurrent


subject: UNII:2S9ZZM9Q9V

object_name: lymphangioleiomyomatosis


subject: UNII:2S9ZZM9Q9V

object_name: lung lymphangioleiomyomatosis


subject: UNII:2S9ZZM9Q9V

object_name: soft tissue neoplasm


subject: UNII:PQX0D8J21J

subject_name: Cetuximab

object_name: Erdheim-Chester disease


subject: UNII:PQX0D8J21J

object_name: Castleman disease


subject: UNII:PQX0D8J21J

object_name: Metastatic urothelial carcinoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Malignant Neoplasm


subject: UNII:PQX0D8J21J

object_name: malignant urinary system neoplasm


subject: UNII:PQX0D8J21J

object_name: digestive system carcinoma


subject: UNII:PQX0D8J21J

object_name: male reproductive organ cancer


subject: UNII:PQX0D8J21J

object_name: female reproductive organ cancer


subject: UNII:PQX0D8J21J

object_name: refractory malignant neoplasm


subject: UNII:PQX0D8J21J

object_name: Recurrent Digestive System Carcinoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Male Reproductive System Carcinoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Female Reproductive System Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UNII:PQX0D8J21J

object_name: thoracic cancer


subject: UNII:PQX0D8J21J

object_name: malignant endocrine neoplasm


subject: UNII:PQX0D8J21J

object_name: Stage IVA Pharyngeal Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage III Breast Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UNII:PQX0D8J21J

object_name: Stage IIIB Breast Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IIIA Breast Carcinoma


subject: UNII:PQX0D8J21J

object_name: respiratory system cancer


subject: UNII:PQX0D8J21J

object_name: Stage IV Pharynx Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage III Pharynx Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IVB Pharyngeal Carcinoma


subject: UNII:PQX0D8J21J

object_name: Stage IVC Pharyngeal Carcinoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Thyroid Carcinoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: UNII:PQX0D8J21J

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UNII:PQX0D8J21J

object_name: Pharyngeal cancer recurrent


subject: UNII:PQX0D8J21J

object_name: Breast cancer recurrent


subject: UNII:PQX0D8J21J

object_name: lymphangioleiomyomatosis


subject: UNII:PQX0D8J21J

object_name: lung lymphangioleiomyomatosis


subject: UNII:PQX0D8J21J

object_name: mesothelial neoplasm


subject: UNII:PQX0D8J21J

object_name: neurofibromatosis


subject: UNII:PQX0D8J21J

object_name: NF2-related schwannomatosis


subject: UNII:PQX0D8J21J

object_name: vestibular schwannomatosis


subject: UNII:PQX0D8J21J

object_name: soft tissue neoplasm


subject: UMLS:C0879636

subject_name: IMC C225

object_name: Erdheim-Chester disease


subject: UMLS:C0879636

object_name: Castleman disease


subject: UMLS:C0879636

object_name: Metastatic urothelial carcinoma


subject: UMLS:C0879636

object_name: Recurrent Malignant Neoplasm


subject: UMLS:C0879636

object_name: malignant urinary system neoplasm


subject: UMLS:C0879636

object_name: digestive system carcinoma


subject: UMLS:C0879636

object_name: male reproductive organ cancer


subject: UMLS:C0879636

object_name: female reproductive organ cancer


subject: UMLS:C0879636

object_name: refractory malignant neoplasm


subject: UMLS:C0879636

object_name: Recurrent Digestive System Carcinoma


subject: UMLS:C0879636

object_name: Recurrent Male Reproductive System Carcinoma


subject: UMLS:C0879636

object_name: Recurrent Female Reproductive System Carcinoma


subject: UMLS:C0879636

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: UMLS:C0879636

object_name: thoracic cancer


subject: UMLS:C0879636

object_name: malignant endocrine neoplasm


subject: UMLS:C0879636

object_name: Stage IVA Pharyngeal Carcinoma


subject: UMLS:C0879636

object_name: Stage III Breast Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IIIC Breast Cancer AJCC v7


subject: UMLS:C0879636

object_name: Stage IIIB Breast Carcinoma


subject: UMLS:C0879636

object_name: Stage IIIA Breast Carcinoma


subject: UMLS:C0879636

object_name: respiratory system cancer


subject: UMLS:C0879636

object_name: Stage IV Pharynx Carcinoma


subject: UMLS:C0879636

object_name: Stage III Pharynx Carcinoma


subject: UMLS:C0879636

object_name: Stage IVB Pharyngeal Carcinoma


subject: UMLS:C0879636

object_name: Stage IVC Pharyngeal Carcinoma


subject: UMLS:C0879636

object_name: Recurrent Thyroid Carcinoma


subject: UMLS:C0879636

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: UMLS:C0879636

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: UMLS:C0879636

object_name: Pharyngeal cancer recurrent


subject: UMLS:C0879636

object_name: Breast cancer recurrent


subject: UMLS:C0879636

object_name: lymphangioleiomyomatosis


subject: UMLS:C0879636

object_name: lung lymphangioleiomyomatosis


subject: UMLS:C0879636

object_name: mesothelial neoplasm


subject: UMLS:C0879636

object_name: neurofibromatosis


subject: UMLS:C0879636

object_name: NF2-related schwannomatosis


subject: UMLS:C0879636

object_name: vestibular schwannomatosis


subject: UMLS:C0879636

object_name: soft tissue neoplasm


subject: CHEBI:79699

subject_name: Temsirolimus

object_name: Erdheim-Chester disease


subject: CHEBI:79699

object_name: Castleman disease


subject: CHEBI:79699

object_name: Metastatic urothelial carcinoma


subject: CHEBI:79699

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:79699

object_name: malignant urinary system neoplasm


subject: CHEBI:79699

object_name: digestive system carcinoma


subject: CHEBI:79699

object_name: male reproductive organ cancer


subject: CHEBI:79699

object_name: female reproductive organ cancer


subject: CHEBI:79699

object_name: Recurrent Digestive System Carcinoma


subject: CHEBI:79699

object_name: Recurrent Male Reproductive System Carcinoma


subject: CHEBI:79699

object_name: Recurrent Female Reproductive System Carcinoma


subject: CHEBI:79699

object_name: thoracic cancer


subject: CHEBI:79699

object_name: malignant endocrine neoplasm


subject: CHEBI:79699

object_name: Stage IVA Pharyngeal Carcinoma


subject: CHEBI:79699

object_name: respiratory system cancer


subject: CHEBI:79699

object_name: Stage IV Pharynx Carcinoma


subject: CHEBI:79699

object_name: Stage III Pharynx Carcinoma


subject: CHEBI:79699

object_name: Stage IVB Pharyngeal Carcinoma


subject: CHEBI:79699

object_name: Stage IVC Pharyngeal Carcinoma


subject: CHEBI:79699

object_name: lip and oral cavity carcinoma


subject: CHEBI:79699

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:79699

object_name: Pharyngeal cancer recurrent


subject: CHEBI:79699

object_name: lymphangioleiomyomatosis


subject: CHEBI:79699

object_name: lung lymphangioleiomyomatosis


subject: CHEBI:79699

object_name: mesothelial neoplasm


subject: CHEBI:79699

object_name: neurofibromatosis


subject: CHEBI:79699

object_name: NF2-related schwannomatosis


subject: CHEBI:79699

object_name: vestibular schwannomatosis


subject: CHEBI:79699

object_name: soft tissue neoplasm


subject: CHEBI:168243

subject_name: Valproic acid glucuronide

object_name: Embolism, Tumor


subject: CHEBI:168243

object_name: Erdheim-Chester disease


subject: CHEBI:168243

object_name: Castleman disease


subject: CHEBI:168243

object_name: Metastatic urothelial carcinoma


subject: CHEBI:168243

object_name: Primary malignant neoplasm


subject: CHEBI:168243

object_name: childhood malignant neoplasm


subject: CHEBI:168243

object_name: Malignant obstetric neoplasm


subject: CHEBI:168243

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:168243

object_name: malignant urinary system neoplasm


subject: CHEBI:168243

object_name: digestive system carcinoma


subject: CHEBI:168243

object_name: male reproductive organ cancer


subject: CHEBI:168243

object_name: female reproductive organ cancer


subject: CHEBI:168243

object_name: refractory malignant neoplasm


subject: CHEBI:168243

object_name: Recurrent Digestive System Carcinoma


subject: CHEBI:168243

object_name: Recurrent Male Reproductive System Carcinoma


subject: CHEBI:168243

object_name: Recurrent Female Reproductive System Carcinoma


subject: CHEBI:168243

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:168243

object_name: thoracic cancer


subject: CHEBI:168243

object_name: malignant endocrine neoplasm


subject: CHEBI:168243

object_name: Stage IVA Pharyngeal Carcinoma


subject: CHEBI:168243

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:168243

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:168243

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:168243

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:168243

object_name: respiratory system cancer


subject: CHEBI:168243

object_name: Stage IV Pharynx Carcinoma


subject: CHEBI:168243

object_name: Stage III Pharynx Carcinoma


subject: CHEBI:168243

object_name: Stage IVB Pharyngeal Carcinoma


subject: CHEBI:168243

object_name: Stage IVC Pharyngeal Carcinoma


subject: CHEBI:168243

object_name: lip and oral cavity carcinoma


subject: CHEBI:168243

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:168243

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:168243

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:168243

object_name: Pharyngeal cancer recurrent


subject: CHEBI:168243

object_name: Breast cancer recurrent


subject: CHEBI:168243

object_name: lymphangioleiomyomatosis


subject: CHEBI:168243

object_name: lung lymphangioleiomyomatosis


subject: CHEBI:168243

object_name: mesothelial neoplasm


subject: CHEBI:168243

object_name: thyroid tumor


subject: CHEBI:168243

object_name: thyroid cancer


subject: CHEBI:168243

object_name: neurofibromatosis


subject: CHEBI:168243

object_name: NF2-related schwannomatosis


subject: CHEBI:168243

object_name: vestibular schwannomatosis


subject: CHEBI:168243

object_name: soft tissue neoplasm


subject: CHEBI:39867

subject_name: Valproic acid

object_name: Embolism, Tumor


subject: CHEBI:39867

object_name: Erdheim-Chester disease


subject: CHEBI:39867

object_name: Castleman disease


subject: CHEBI:39867

object_name: Metastatic urothelial carcinoma


subject: CHEBI:39867

object_name: Primary malignant neoplasm


subject: CHEBI:39867

object_name: childhood malignant neoplasm


subject: CHEBI:39867

object_name: Malignant obstetric neoplasm


subject: CHEBI:39867

object_name: Recurrent Malignant Neoplasm


subject: CHEBI:39867

object_name: malignant urinary system neoplasm


subject: CHEBI:39867

object_name: digestive system carcinoma


subject: CHEBI:39867

object_name: male reproductive organ cancer


subject: CHEBI:39867

object_name: female reproductive organ cancer


subject: CHEBI:39867

object_name: refractory malignant neoplasm


subject: CHEBI:39867

object_name: Recurrent Digestive System Carcinoma


subject: CHEBI:39867

object_name: Recurrent Male Reproductive System Carcinoma


subject: CHEBI:39867

object_name: Recurrent Female Reproductive System Carcinoma


subject: CHEBI:39867

object_name: Stage IV Breast Cancer AJCC v6 and v7


subject: CHEBI:39867

object_name: thoracic cancer


subject: CHEBI:39867

object_name: malignant endocrine neoplasm


subject: CHEBI:39867

object_name: Stage IVA Pharyngeal Carcinoma


subject: CHEBI:39867

object_name: Stage III Breast Cancer AJCC v7


subject: CHEBI:39867

object_name: Stage IIIC Breast Cancer AJCC v7


subject: CHEBI:39867

object_name: Stage IIIB Breast Carcinoma


subject: CHEBI:39867

object_name: Stage IIIA Breast Carcinoma


subject: CHEBI:39867

object_name: respiratory system cancer


subject: CHEBI:39867

object_name: Stage IV Pharynx Carcinoma


subject: CHEBI:39867

object_name: Stage III Pharynx Carcinoma


subject: CHEBI:39867

object_name: Stage IVB Pharyngeal Carcinoma


subject: CHEBI:39867

object_name: Stage IVC Pharyngeal Carcinoma


subject: CHEBI:39867

object_name: lip and oral cavity carcinoma


subject: CHEBI:39867

object_name: Recurrent Thyroid Carcinoma


subject: CHEBI:39867

object_name: Recurrent Childhood Soft Tissue Sarcoma


subject: CHEBI:39867

object_name: Recurrent Adult Soft Tissue Sarcoma


subject: CHEBI:39867

object_name: Pharyngeal cancer recurrent


subject: CHEBI:39867

object_name: Breast cancer recurrent


subject: CHEBI:39867

object_name: lymphangioleiomyomatosis


subject: CHEBI:39867

object_name: lung lymphangioleiomyomatosis


subject: CHEBI:39867

object_name: mesothelial neoplasm


subject: CHEBI:39867

object_name: thyroid tumor


subject: CHEBI:39867

object_name: thyroid cancer


subject: CHEBI:39867

object_name: neurofibromatosis


subject: CHEBI:39867

object_name: NF2-related schwannomatosis


subject: CHEBI:39867

object_name: vestibular schwannomatosis


subject: CHEBI:39867

object_name: soft tissue neoplasm


subject: MESH:C584568

subject_name: belotero balance

object_name: Circumoral rhytides


subject: CHEBI:46274

subject_name: (Z)-octadec-11-enyl acetate

object_name: acute myeloid leukemia by FAB classification


subject: CHEBI:46274

object_name: acute myeloid leukemia


subject: CHEBI:46274

object_name: Recurrent disease


subject: CHEBI:46274

object_name: Global Relapse in Viscera


subject: CHEBI:46274

object_name: Global Relapse in Lymph Nodes


subject: CHEBI:46274

object_name: Relapse Following Intervention for Kawasaki Disease


subject: CHEBI:46274

object_name: Global Relapse


subject: CHEBI:46274

object_name: Global Relapse in Skin


subject: CHEBI:46274

object_name: Global Relapse in Blood


subject: CHEBI:46274

object_name: Refractory acute myeloid leukemia


subject: CHEBI:48947

subject_name: Clavulanic acid


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: CHEBI:48947


subject: UMLS:C5779650


subject: UMLS:C5779650


subject: UMLS:C5779650


subject: UMLS:C5779650


subject: UMLS:C5779650


subject: UMLS:C5779650


subject: UMLS:C5779650


subject: UMLS:C5779650


subject: GTOPDB:6803

subject_name: dalteparin

object_name: acute coronary syndrome


subject: UNII:PUE0TO3XDR

subject_name: Dalteparin


subject: GTOPDB:8000

subject_name: tabalumab

object_name: rheumatoid arthritis


subject: CHEMBL.COMPOUND:CHEMBL1743075

subject_name: TABALUMAB


subject: CHEBI:190738

subject_name: Demethylated antipyrine

object_name: Stroke (heart beat)


subject: CHEBI:190738

object_name: Stroke, CTCAE


subject: UNII:S798V6YJRP

subject_name: EDARAVONE


subject: UNII:S798V6YJRP


subject: CHEBI:31530

subject_name: Edaravone


subject: CHEBI:31530


subject: UNII:52CMI0WC3Y

subject_name: Atezolizumab

object_name: Activating EGFR Gene Mutation


subject: UMLS:C3827082


subject: UMLS:C3540778

subject_name: Glucocorticoid inhalants for obstructive airway disease

object_name: autoimmune pancreatitis type 1


subject: CHEBI:24261

subject_name: glucocorticoid


subject: UMLS:C3540777

subject_name: Glucocorticoids, Systemic


subject: CHEBI:8764

subject_name: Mycophenolate mofetil


subject: CHEBI:167450

subject_name: Monomethyl fumarate


subject: CHEBI:6432

subject_name: Levamisole

object_name: acne


subject: CHEBI:231651

subject_name: Vosaroxin

object_name: Adult Myelodysplastic Syndrome


subject: CHEBI:231651

object_name: childhood myelodysplastic syndrome


subject: CHEBI:231651

object_name: Myelodysplastic Syndrome, CTCAE


subject: CHEBI:81916

subject_name: Pancrelipase

object_name: pancreatic adenocarcinoma


subject: UNII:FQ3DRG0N5K


subject: UMLS:C0111046

subject_name: Creon


subject: UMLS:C1302030

subject_name: amylase / lipase / protease


subject: PUBCHEM.COMPOUND:6427057

subject_name: ivermectin

object_name: Severe Dengue


subject: CHEBI:6078

subject_name: Ivermectin


subject: UMLS:C4287734

subject_name: Microparticle MDP/Bacterial DNA-containing MIS416

object_name: primary progressive multiple sclerosis


subject: CHEBI:25681

subject_name: Omega-3 fatty acids

object_name: Periodontal Attachment Loss


subject: UMLS:C3536908

subject_name: Omega-3 Fatty Acid [EPC]


subject: UMLS:C0393031

object_name: pancreatic neoplasm


subject: CHEBI:167309

subject_name: Methadone

object_name: Postoperative Complications


subject: CHEBI:167309

object_name: sign or symptom


subject: CHEBI:167309

object_name: Neurologic Manifestations


subject: CHEBI:167309

object_name: Pathologic Processes


subject: CHEBI:167309

object_name: Neurological Signs and Symptoms


subject: CHEBI:167309

object_name: bladder tumor


subject: CHEBI:167309

object_name: urinary bladder carcinoma


subject: CHEBI:167309

object_name: urinary bladder cancer


subject: CHEBI:167309

object_name: childhood bladder carcinoma


subject: UNII:1B56C968OA

subject_name: Becaplermin

object_name: anal fistula


subject: UNII:1B56C968OA

object_name: Anal Fistula, CTCAE


subject: CHEBI:2704

subject_name: Anastrozole

object_name: cerebrovascular disorder


subject: CHEBI:49662

subject_name: Indomethacin


subject: UMLS:C2348756

subject_name: Testosterone Gel


subject: PUBCHEM.COMPOUND:22064497

subject_name: Elagolix


subject: UNII:P93RUU11P7

subject_name: INOTUZUMAB

object_name: Recurrent Adult Acute Lymphoblastic Leukemia


subject: UNII:P93RUU11P7

object_name: Philadelphia chromosome positive adult precursor acute lymphoblastic leukemia


subject: UMLS:C1328139


subject: UMLS:C1328139


subject: PUBCHEM.COMPOUND:91826462

subject_name: Sutent

object_name: renal carcinoma


subject: PUBCHEM.COMPOUND:91826462

object_name: kidney cancer


subject: CHEBI:145371

subject_name: Binimetinib

object_name: KRAS mutation-related tumors


subject: CHEBI:5801

subject_name: Hydroxychloroquine


subject: CHEBI:4026

subject_name: cyclophosphamide hydrate

object_name: Chronic lymphocytic leukaemia stage 0


subject: CHEBI:4027

subject_name: Cyclophosphamide


subject: CHEBI:28887

subject_name: Ofatumumab


subject: CHEBI:28887

object_name: B-cell small lymphocytic lymphoma stage I


subject: CHEBI:28887

object_name: B-cell small lymphocytic lymphoma stage II


subject: CHEBI:28887

object_name: B-cell small lymphocytic lymphoma stage IV


subject: CHEBI:28887

object_name: B-cell small lymphocytic lymphoma stage III


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: UMLS:C1541395


subject: PUBCHEM.COMPOUND:4739

subject_name: Vidarbine


subject: PUBCHEM.COMPOUND:4739

object_name: Chronic lymphocytic leukaemia stage 1


subject: PUBCHEM.COMPOUND:4739


subject: PUBCHEM.COMPOUND:4739

object_name: Chronic lymphocytic leukaemia stage 2


subject: PUBCHEM.COMPOUND:4739

object_name: Chronic lymphocytic leukaemia stage 4


subject: PUBCHEM.COMPOUND:4739


subject: PUBCHEM.COMPOUND:4739


subject: PUBCHEM.COMPOUND:4739

object_name: Chronic lymphocytic leukaemia stage 3


subject: PUBCHEM.COMPOUND:4739


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:229687


subject: CHEBI:27834

subject_name: Pentostatin


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: CHEBI:27834


subject: PUBCHEM.COMPOUND:4715169

subject_name: 3-(Aminomethyl)-5-methylhexanoic acid

object_name: Tactile Allodynia


subject: CHEBI:64356

subject_name: Pregabalin


subject: DRUGBANK:DB06184

object_name: non-small cell lung carcinoma


subject: CHEBI:42446

subject_name: Esflurbiprofen

object_name: Postoperative shivering


subject: CHEBI:5130

subject_name: Flurbiprofen


subject: UNII:EB87433V6F


subject: PUBCHEM.COMPOUND:21982135


subject: CHEBI:73038

subject_name: Parecoxib


subject: UNII:SSB9S6N20R

object_name: Diabetic peripheral neuropathy


subject: CHEBI:135530

subject_name: Solifenacin

object_name: Incontinence


subject: PUBCHEM.COMPOUND:13175121

subject_name: Dienogest

object_name: Endometrioma


subject: CHEBI:94518

subject_name: Tranexamic acid

object_name: Periorbital disorder


subject: CHEBI:94518

object_name: eyelid disorder


subject: CHEBI:6456

subject_name: Lidocaine

object_name: Myoclonus


subject: UMLS:C1831729

subject_name: FET F-18

object_name: brain neoplasm


subject: UMLS:C1831729

object_name: Recurrent Childhood Glioblastoma


subject: UMLS:C1831729

object_name: Recurrent Glioblastoma


subject: UMLS:C1831729

object_name: Recurrent WHO Grade 3 Glioma


subject: UMLS:C1831729

object_name: low grade glioma


subject: PUBCHEM.COMPOUND:67395


subject: PUBCHEM.COMPOUND:67395


subject: PUBCHEM.COMPOUND:67395


subject: PUBCHEM.COMPOUND:67395


subject: UMLS:C1709081

subject_name: Mouse gp100 Plasmid DNA Vaccine

object_name: ocular melanoma


subject: UMLS:C1709081

object_name: uveal melanoma


subject: UMLS:C5203186

subject_name: Atezolizumab Liquid Injection

object_name: squamous cell carcinoma


subject: UMLS:C5203186

object_name: carcinoma of esophagus


subject: UMLS:C5203186

object_name: esophageal cancer


subject: UMLS:C5203186

object_name: Childhood Esophageal Carcinoma


subject: UMLS:C5203186

object_name: neoplasm of esophagus


subject: UMLS:C5203186

object_name: Disseminated Malignant Neoplasm


subject: UMLS:C5203186

object_name: Embolism, Tumor


subject: UMLS:C5203186

object_name: Neoplasm Metastasis


subject: CHEBI:72317

subject_name: Cabozantinib


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:72317


subject: CHEBI:64312

subject_name: Memantine

object_name: Hematoma, Subdural, Chronic


subject: CHEBI:28834

object_name: fallopian tube carcinoma


subject: CHEBI:28834

object_name: fallopian tube cancer


subject: CHEBI:28834

object_name: primary peritoneal carcinoma


subject: CHEBI:28834

object_name: papillary serous cystadenocarcinoma


subject: CHEBI:28834

object_name: peritoneal carcinoma


subject: CHEBI:28834

object_name: ovarian cancer


subject: CHEBI:28834

object_name: ovarian neoplasm


subject: CHEBI:28834

object_name: ovarian carcinoma


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: UMLS:C4305918


subject: PUBCHEM.COMPOUND:64730

subject_name: acid citrate dextrose


subject: PUBCHEM.COMPOUND:64730


subject: PUBCHEM.COMPOUND:64730


subject: PUBCHEM.COMPOUND:64730


subject: PUBCHEM.COMPOUND:64730


subject: PUBCHEM.COMPOUND:64730